ABL Bio Inc

Chart & performance

D1W1MN

P/E

—

P/S

54.26

EPS

—

Div yield, %

—

Shrs. gr., 5y

3.17%

Rev. gr., 5y

57.82%

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.

URL

http://www.ablbio.com/

IPO date

Dec 19, 2018

Employees

Domiciled in

Incorporated in

Valuation

No data to show